CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
TOTAL REVENUE	$ 33,750	$ 10,113
COST OF REVENUES	(4,127)	(8,180)
RESEARCH AND DEVELOPMENT EXPENSES	(5,426)	(3,475)
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES	(3,051)	(2,603)
OPERATING INCOME (LOSS)	21,146	(4,145)
FINANCIAL EXPENSES	(193)	(6)
FINANCIAL INCOME	188	419
FINANCIAL INCOME (EXPENSES), NET	(5)	413
INCOME (LOSS) BEFORE TAXES ON INCOME	21,141	(3,732)
TAXES ON INCOME (TAX BENEFIT)	(2,824)	113
NET INCOME (LOSS)	$ 18,317	$ (3,619)
EARNINGS (LOSS) PER SHARE OF COMMON STOCK - BASIC (in dollars per share)	$ 0.23	$ (0.05)
EARNINGS (LOSS) PER SHARE OF COMMON STOCK - DILUTED (in dollars per share)	$ 0.22	$ (0.05)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING EARNINGS (LOSS) PER SHARE - BASIC (in shares)	79,848,892	76,611,980
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING EARNINGS (LOSS) PER SHARE - DILUTED (in shares)	83,048,596	76,611,980
Goods
TOTAL REVENUE	$ 7,419	$ 9,995
License and R&D Services
TOTAL REVENUE	$ 26,331	$ 118